Papillary microcarcinoma in three generations of the first degree relatives

Abstract

Family papillary microcarcinoma of the thyroid gland is observed in 3–10 % of patients with cancer from follicular epithelial cells. Diagnosis and treatment are controversial. Three patients from the same family of the first degree of kinship were operated for family papillary microcarcinoma of the thyroid gland in Voronezh Regional Clinical Hospital No. 1. Only the first patient complained of the neck deformity, her son and granddaughter had an asymptomatic course of the disease. Metastases to the lymph nodes of the neck and bilateral localization of the tumor were not revealed. In the third generation, multifocal tumor growth was diagnosed at the age of 19. All patients underwent thyroidectomy. In the first patient, the period of relapse–free follow-up after surgery was 18 years, in the second and third – 5 years.

In the family form of papillary thyroid carcinoma, we consider active screening of relatives justified since the disease in the new generation may develop at a younger age and with the risk of multifocal thyroid damage even in microcarcinomas.

Keywords

Family papillary thyroid cancer

References

[1] Бабинская С.А., Калинченко Н.Ю., Ильин А.А., Северская Н.В., Чеботарева И.В., Нижегородова К.С., Румянцев П.О., Тюльпаков А.Н. Клинический случай наследственной формы папиллярного рака щитовидной железы, ассоциированного с дефектом гена DICER1. Проблемы эндокринологии 2017; 63 (5): 320–324 / Babinskaya S.A., Kalinchenko N.Y., Ilyin A.A., Severskaya N.V., Chebotareva I.V., Nizhegorodova K.S., Rumyantsev P.O., Tiulpakov A.N. A clinical case of hereditary papillary thyroid carcinoma associated with a germline DICER1 gene mutation. Problems of Endocrinology 2017; 63 (5): 320–324. DOI: 10.14341/probl2017635320-324 (in Russian).

[2] Li Z., Zhang H., Yan Y., Li X., Jia M., Zhou H., Lu X. Clinical relevance and outcome of familial papillary thyroid cancer: a single institution study of 626 familial cases. Front Endocrinol (Lausanne) 2023; 14 (14): 1200855. DOI: 10.3389/fendo.2023.1200855.

[3] Казубская Т.П., Козлова В.М., Кондратьева Т.Т., Павловская А.И., Марахонов А.В., Баранова А.В., Иванова Н.И., Степанова А.А., Поляков А.В., Белев Н.Ф., Бржезовский В.Ж. Фолликулярно-клеточный (папиллярный и фолликулярный) рак щитовидной железы, генетическая обусловленность и молекулярные маркеры диагностики. Архив патологии 2014; 76 (5): 3–12 / Kazubskaja T.P., Kozlova V.M., Kondrat'eva T.T., Pavlovskaja A.I., Marahonov A.V., Baranova A.V., Ivanova N.I., Stepanova A.A., Poljakov A.V., Belev N.F., Brzhezovskij V.Zh. Follicular-cellular (papillary and follicular) thyroid cancer, genetic conditioning and molecular markers of diagnosis. Russian Journal Archive of Pathology 2014; 76 (5): 3–12 (in Russian).

[4] Capezzone M., Robenshtok E., Cantara S., Castagna M.G. Familial non-medullary thyroid cancer: a critical review. J Endocrinol Invest 2021; 44 (5): 943–950. DOI: 10.1007/s40618-020-01435-x.

[5] Sippel R.S., Caron N.R., Clark O.H. An Evidence-based Approach to Familial Nonmedullary Thyroid Cancer: Screening, Clinical Management, and Follow-up. World J Surg 2007; 31 (5): 924–33. DOI: 10.1007/s00268-006-0847-1.

[6] Charkes N.D. On the prevalence of familial nonmedullary thyroid cancer in multiply affected kindreds. Thyroid. 2006; 16 (2): 181–6. DOI: 10.1089/thy.2006.16.181.

[7] Rashid M.O., Haq N., Farooq S., Kiran Z., Siddique S., Pervez S., Islam N. Three siblings with familial non-medullary thyroid carcinoma: a case series. J Med Case Rep. 2016; 2 (10): 213. DOI: 10.1186/s13256-016-0995-3.

[8] Capezzone M., Secchi C., Fralassi N., Cantara S., Brilli L., Ciuoli C., Pilli T., Maino F., Forle O.R., Pacini F. Should familial disease be considered as a negative prognostic factor in micropapillary thyroid carcinoma? J Endocrinol Invest 2019; 42 (10): 1205–1213. DOI: 10.1007/s40618-019-010390.

[9] Alsanea O., Clark O.H. Familial thyroid cancer. Curr Opin Oncol. 2001; 13 (1): 44–51. DOI: 10.1097/00001622-200101000-00009.

[10] Lakis M., Giannaku A., Nokel P.J., Wiseman D., Gara S.K., Pate D., Sater Z.A., Kushchayeva E.Y., Klubo-Gwiezdzinska J., Nilubol N., Merino M.J., Magazine K.E. Do patients with familial nonmedullary thyroid cancer present with more aggressive disease? Surgery. 2019; 165 (1): 50–57. DOI: 10.1016/ j.surg.2018.05.075.

[11] Robenshtok E., Tzvetov G., Grozinsky-Glasberg S., Shraga-Slutzky I., Weinstein R., Lazar L., Serov S., Singer J., Hirsch D., Shimon I., Benbassat C. Clinical characteristics and outcome of familial nonmedullary thyroid cancer: a retrospective controlled study. Thyroid. 2011; 21 (1): 43–8. DOI: 10.1089/thy.2009.0406.

[12] Loh K.C. Familial nonmedullary thyroid carcinoma: a meta-review of case series. Thyroid. 1997; 7 (1): 107–13. DOI: 10.1089/thy.1997.7.107.

[13] Ríos A., Rodríguez M.A., Puñal J.A., Moreno P., Mercader E., Ferrero E., Ruiz-Pardo J., Morlan M.A., Martin J., Duran-Poveda M., Bravo J.M., Casanova D., Salvador Egea M.P., Torregrosa N.M., Exposito-Rodríguez A., Martínez-Fernández G., Carrión A.M., Vidal O., Herrera F., Ruiz-Merino G., Rodríguez J.M. Biological behavior of familial papillary thyroid microcarcinoma: Spanish multicenter study. Langenbecks Arch Surg. 2022; 407 (8): 3631–3642. DOI: 10.1007/s00423-022-02704-4.

[14] Sung T.-Y., Lee Y., Jong H.Y., Chung K.-W., Hong S.J. Surgical Management of Familial Papillary Thyroid Microcarcinoma: A Single Institution Study of 94 Cases. World J Surg. 2015; 39 (8): 1930–5. DOI: 10.1007/s00268-015-3064-y.

RIGHTS & PERMISSIONS

Eco-Vector